NCT05311865

Brief Summary

The ITOC study is a cluster randomised, controlled, multicentre trial in Paris region, France. The intervention is an 8-hour indoor clubbing event with no mask wearing, no social distancing, at maximum room capacity. 1,200 healthy volunteers aged 18-49 years and fully vaccinated will be included. Participants are recruited by group of up to 10, to be randomized 2:1 to experimental group (800 volunteers in a venue ) or control group (400 volunteers asked to stay at home). All participants will provide a salivary sample the day of experiment and seven days later. Participants will also answer surveys on the social and psychological impact of lockdown and indoor club closing, attitude towards vaccination, behaviour at risk of COVID-19 transmission during the day of the event (for both groups) as well as follow-up surveys on symptoms that participant may experience. Virological analyses include polymerase chain reaction (PCR) of salivary samples and air of the venue, investigating SARS-CoV-2 PCR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,216

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 4, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2022

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 5, 2022

Completed
Last Updated

April 5, 2022

Status Verified

April 1, 2022

Enrollment Period

1 month

First QC Date

March 8, 2022

Last Update Submit

April 1, 2022

Conditions

Keywords

SARS CoV-2TransmissionvaccinatedNight-club

Outcome Measures

Primary Outcomes (1)

  • Number of positive RT-PCR at day 7

    Number of participants in each groups with a positive salivary RT-PCR

    Day 7

Secondary Outcomes (9)

  • Number of SARS-CoV-2 infection cases

    Day 5 up to day 10

  • Number of participants with seasonal respiratory viruses

    Day 0 and day 7

  • Number of symptomatic and asymptomatic respiratory infection

    Day 5 to day 10

  • Number of detected virus in the air

    Day 0

  • Number of mutations, deletions and insertions on the viral genome in participants samples

    Day 0 and day 7

  • +4 more secondary outcomes

Study Arms (2)

participating to the event

EXPERIMENTAL
Other: Club event

Non partipating to the event

NO INTERVENTION

Interventions

Participate in a club event without a mask, indoors, with vaccinated people.

participating to the event

Eligibility Criteria

Age18 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged between 18 and 49 years old
  • Vaccination completed
  • People who declared to have no risk factor to severe form for Covid-19 disease
  • People who declared not to live in the same place as someone with these risk factors
  • People residing in Ile-de-France area
  • People affiliated with the the French social security citizen scheme

You may not qualify if:

  • Presence of symptoms of COVID in the 2 weeks before the event
  • Pregnant woman or woman who declares not having an effective contraception method
  • Self identification of medical conditions or comorbidities identified as a proven risk of severe COVID infection
  • People living with a person with these risk factors
  • Confirmed diagnosis of SARS-CoV-2 within two weeks before the event
  • Participants under tutorship or curatorship;
  • Underage participants;
  • Participants unable to give free and informed consent;
  • Participants not affiliated to the French social security citizen scheme: obligation to join a social security scheme or be a beneficiary thereof.
  • Participants under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ANRS

Paris, 75013, France

Location

Related Publications (2)

  • Luong Nguyen LB, Goupil de Bouille J, Menant L, Noret M, Dumas A, Salmona M, Le Goff J, Delaugerre C, Crepey P, Zeggagh J; ITOC Study Group. A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study). Clin Infect Dis. 2023 Dec 15;77(12):1648-1655. doi: 10.1093/cid/ciad603.

  • Goupil de Bouille J, Luong Nguyen LB, Crepey P, Garlantezec R, Dore V, Dumas A, Ben Mechlia M, Tattevin P, Gaudart J, Spire B, Lert F, Yazdanpanah Y, Delaugerre C, Noret M, Zeggagh J. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol. Front Public Health. 2022 Nov 4;10:981213. doi: 10.3389/fpubh.2022.981213. eCollection 2022.

Study Officials

  • Yazdan Yazdanpanah, Pr

    ANRS, Emerging Infectious Diseases

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Open-label, multicenter, randomized controlled intervention study with 1200 participants distributed 2: 1 in two groups of volunteers.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2022

First Posted

April 5, 2022

Study Start

September 4, 2021

Primary Completion

October 17, 2021

Study Completion

February 26, 2022

Last Updated

April 5, 2022

Record last verified: 2022-04

Locations